{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:53:45Z","timestamp":1791107625690,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Bladder cancer is one of the most common malignancies and causes hundreds of thousands of deaths worldwide each year. Bladder cancer is strongly associated with exposure to environmental carcinogens. It is believed that DNA damage generated by environmental carcinogens and their metabolites causes development of bladder cancer. Nucleotide excision repair (NER) is the major DNA repair pathway for repairing bulk DNA damage generated by most environmental carcinogens, and XPC is a DNA damage recognition protein required for initiation of the NER process. Recent studies demonstrate reduced levels of XPC protein in tumors for a majority of bladder cancer patients. In this work we investigated the role of histone deacetylases (HDACs) in XPC gene silencing and bladder cancer development. The results of our HDAC inhibition study revealed that the treatment of HTB4 and HTB9 bladder cancer cells with the HDAC inhibitor valproic acid (VPA) caused an increase in transcription of the XPC gene in these cells. The results of our chromatin immunoprecipitation (ChIP) studies indicated that the VPA treatment caused increased binding of both CREB1 and Sp1 transcription factors at the promoter region of the XPC gene for both HTB4 and HTB9 cells. The results of our immunohistochemistry (IHC) staining studies further revealed a strong correlation between the over-expression of HDAC4 and increased bladder cancer occurrence (<jats:italic>p<\/jats:italic> &lt; 0.001) as well as a marginal significance of increasing incidence of HDAC4 positivity seen with an increase in severity of bladder cancer (<jats:italic>p<\/jats:italic> = 0.08). In addition, the results of our caspase 3 activation studies demonstrated that prior treatment with VPA increased the anticancer drug cisplatin-induced activation of caspase 3 in both HTB4 and HTB9 cells. All of these results suggest that the HDACs negatively regulate transcription of the XPC gene in bladder cancer cells and contribute to the severity of bladder tumors.<\/jats:p>","DOI":"10.1186\/1756-8722-4-17","type":"journal-article","created":{"date-parts":[[2011,4,26]],"date-time":"2011-04-26T06:17:24Z","timestamp":1303798644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer"],"prefix":"10.1186","volume":"4","author":[{"given":"Xiaoxin S","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,20]]},"reference":[{"key":"155_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00345-009-0383-3","volume":"27","author":"M Ploeg","year":"2009","unstructured":"Ploeg M, Aben KKH, Kiemeney LA: The present and future burden of urinary bladder cancer in the world. World J Urol. 2009, 27: 289-293. 10.1007\/s00345-009-0383-3.","journal-title":"World J Urol"},{"key":"155_CR2","volume-title":"BC Decker Inc","author":"DW Kufe","year":"2006","unstructured":"Kufe DW, Bast RBJ, Hait WH, Hong WH, Pollock RE, Weichselbaum RR, Holland JF, Frei EI: Cancer Medicine 7. BC Decker Inc. 2006"},{"key":"155_CR3","volume-title":"DNA repair and mutagenesis","author":"EC Friedberg","year":"1995","unstructured":"Friedberg EC, Walker GC, Siede W: DNA repair and mutagenesis. 1995, ASM published, Washington, D.C, First","edition":"First"},{"key":"155_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev.biochem.73.011303.073723","volume":"73","author":"A Sancar","year":"2004","unstructured":"Sancar A, Lindsey-Boltz LA, Unsal-Kaccmaz K, Linn S: Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004, 73: 39-85. 10.1146\/annurev.biochem.73.011303.073723.","journal-title":"Annu Rev Biochem"},{"key":"155_CR5","volume-title":"DNA repair and mutagenesis","author":"EC Friedberg","year":"2006","unstructured":"Friedberg EC, Walker GC, Siede W, Wood RD, Schultz RA, Ellenberger T: DNA repair and mutagenesis. 2006, ASM Press, Washington D.C, Second","edition":"Second"},{"key":"155_CR6","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1126\/science.7801121","volume":"266","author":"PC Hanawalt","year":"1994","unstructured":"Hanawalt PC: Transcription-coupled repair and human disease. Science. 1994, 266: 1957-1958. 10.1126\/science.7801121.","journal-title":"Science"},{"key":"155_CR7","doi-asserted-by":"publisher","first-page":"8949","DOI":"10.1038\/sj.onc.1206096","volume":"21","author":"PC Hanawalt","year":"2002","unstructured":"Hanawalt PC: Subpathways of nucleotide excision repair and their regulation. Oncogene. 2002, 21: 8949-8956. 10.1038\/sj.onc.1206096.","journal-title":"Oncogene"},{"key":"155_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.molcel.2005.09.022","volume":"20","author":"AH Sarker","year":"2005","unstructured":"Sarker AH, Tsutakawa SE, Kostek S, Ng C, Shin DS, Peris M, Campeau E, Tainer JA, Nogales E, Cooper PK: Recognition of RNA polymerase II and transcription bubbles by XPG, CSB, and TFIIH: insights for transcription-coupled repair and Cockayne Syndrome. Mol Cell. 2005, 20: 187-198. 10.1016\/j.molcel.2005.09.022.","journal-title":"Mol Cell"},{"key":"155_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.emboj.7600933","volume":"25","author":"JP Laine","year":"2006","unstructured":"Laine JP, Egly JM: Initiation of DNA repair mediated by a stalled RNA polymerase IIO. EMBO J. 2006, 25: 387-397. 10.1038\/sj.emboj.7600933.","journal-title":"EMBO J"},{"key":"155_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0300-9084(99)80036-4","volume":"81","author":"RD Wood","year":"1999","unstructured":"Wood RD: DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie. 1999, 81: 39-44. 10.1016\/S0300-9084(99)80036-4.","journal-title":"Biochimie"},{"key":"155_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1101\/gad.866301","volume":"15","author":"K Sugasawa","year":"2001","unstructured":"Sugasawa K, Okamoto T, Shimizu Y, Masutani C, Iwai S, Hanaoka F: A multistep damage recognition mechanism for global genomic nucleotide excision repair. Genes Dev. 2001, 15: 507-521. 10.1101\/gad.866301.","journal-title":"Genes Dev"},{"key":"155_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/371432a0","volume":"371","author":"A O'Donovan","year":"1994","unstructured":"O'Donovan A, Davies AA, Moggs JG, West SC, Wood RD: XPG endonuclease makes the 3' incision in human DNA nucleotide excision repair. Nature. 1994, 371: 432-435. 10.1038\/371432a0.","journal-title":"Nature"},{"key":"155_CR13","doi-asserted-by":"publisher","first-page":"11047","DOI":"10.1074\/jbc.271.19.11047","volume":"271","author":"T Matsunaga","year":"1996","unstructured":"Matsunaga T, Park CH, Bessho T, Mu D, Sancar A: Replication protein A confers structure-specific endonuclease activities to the XPF-ERCC1 and XPG subunits of human DNA repair excision nuclease. J Biol Chem. 1996, 271: 11047-11050. 10.1074\/jbc.271.19.11047.","journal-title":"J Biol Chem"},{"key":"155_CR14","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1074\/jbc.272.6.3833","volume":"272","author":"T Bessho","year":"1997","unstructured":"Bessho T, Sancar A, Thompson LH, Thelen MP: Reconstitution of human excision nuclease with recombinant XPF-ERCC1 complex. J Biol Chem. 1997, 272: 3833-3837. 10.1074\/jbc.272.6.3833.","journal-title":"J Biol Chem"},{"key":"155_CR15","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1021\/bi00015a012","volume":"34","author":"MK Shivji","year":"1995","unstructured":"Shivji MK, Podust VN, Hubscher U, Wood RD: Nucleotide excision repair DNA synthesis by DNA polymerase epsilon in the presence of PCNA, RFC, and RPA. Biochemistry. 1995, 34: 5011-5017. 10.1021\/bi00015a012.","journal-title":"Biochemistry"},{"key":"155_CR16","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/nar\/gkh541","volume":"32","author":"G Wang","year":"2004","unstructured":"Wang G, Chuang L, Zhang X, Colton S, Dombkowski A, Reiners J, Diakiw A, Xu XS: The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation. Nucleic Acids Res. 2004, 32: 2231-2240. 10.1093\/nar\/gkh541.","journal-title":"Nucleic Acids Res"},{"key":"155_CR17","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1128\/MCB.21.7.2281-2291.2001","volume":"21","author":"SJ Araujo","year":"2001","unstructured":"Araujo SJ, Nigg EA, Wood RD: Strong functional interactions of TFIIH with XPC and XPG in human DNA nucleotide excision repair, without a preassembled repairosome. Mol Cell Biol. 2001, 21: 2281-2291. 10.1128\/MCB.21.7.2281-2291.2001.","journal-title":"Mol Cell Biol"},{"key":"155_CR18","doi-asserted-by":"publisher","first-page":"9870","DOI":"10.1074\/jbc.275.13.9870","volume":"275","author":"M Yokoi","year":"2000","unstructured":"Yokoi M, Masutani C, Maekawa T, Sugasawa K, Ohkuma Y, Hanaoka F: The xeroderma pigmentosum group C protein complex XPC-HR23B plays an important role in the recruitment of transcription factor IIH to damaged DNA. J Biol Chem. 2000, 275: 9870-9875. 10.1074\/jbc.275.13.9870.","journal-title":"J Biol Chem"},{"key":"155_CR19","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/j.1460-2075.1996.tb00506.x","volume":"15","author":"T Leveillard","year":"1996","unstructured":"Leveillard T, Andera L, Bissonnette N, Schaeffer L, Bracco L, Egly JM, Wasylyk B: Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations. EMBO J. 1996, 15: 1615-1624.","journal-title":"EMBO J"},{"key":"155_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/carcin\/5.4.511","volume":"5","author":"KH Kraemer","year":"1984","unstructured":"Kraemer KH, Lee MM, Scotto J: DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. Carcinogenesis. 1984, 5: 511-514. 10.1093\/carcin\/5.4.511.","journal-title":"Carcinogenesis"},{"key":"155_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archderm.1987.01660260111026","volume":"123","author":"KH Kraemer","year":"1987","unstructured":"Kraemer KH, Myung ML, Scotto J: Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987, 123: 241-250. 10.1001\/archderm.123.2.241.","journal-title":"Arch Dermatol"},{"key":"155_CR22","first-page":"771","volume":"59","author":"DL Cheo","year":"1999","unstructured":"Cheo DL, Burns DK, Meira LB, Houle JF, Friedberg EC: Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53-\/- mice. Cancer Res. 1999, 59: 771-775.","journal-title":"Cancer Res"},{"key":"155_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000062011","volume":"35","author":"EC Friedberg","year":"1999","unstructured":"Friedberg EC, Cheo DL, Meira LB, Reis AM: Cancer predisposition in mutant mice defective in the XPC DNA repair gene. Prog Exp Tumor Res. 1999, 35: 37-52.","journal-title":"Prog Exp Tumor Res"},{"key":"155_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0921-8777(99)00068-3","volume":"459","author":"EC Friedberg","year":"2000","unstructured":"Friedberg EC, Bond JP, Burns DK, Cheo DL, Greenblatt MS, Meira LB, Nahari D, Reis AM: Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition. Mutation Res. 2000, 459: 99-108. 10.1016\/S0921-8777(99)00068-3.","journal-title":"Mutation Res"},{"key":"155_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0027-5107(01)00097-5","volume":"477","author":"LB Meira","year":"2001","unstructured":"Meira LB, Reis AM, Cheo DL, Nahari D, Burns DK, Friedberg EC: Cancer predisposition in mutant mice defective in multiple genetic pathways: uncovering important genetic interactions. Mutation Res. 2001, 477: 51-58.","journal-title":"Mutation Res"},{"key":"155_CR26","first-page":"481","volume":"74","author":"DL Cheo","year":"2003","unstructured":"Cheo DL, Friedberg EC: Use of nucleotide excision repair-deficient mice as a model for chemically induced lung cancer. Methods Mol Med. 2003, 74: 481-491.","journal-title":"Methods Mol Med"},{"key":"155_CR27","doi-asserted-by":"publisher","first-page":"13200","DOI":"10.1073\/pnas.0503133102","volume":"102","author":"MC Hollander","year":"2005","unstructured":"Hollander MC, Philburn RT, Patterson AD, Velasco-Miguel S, Friedberg EC, Linnoila RI, Fornace AJJ: Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis. Proc Natl Acad Sci USA. 2005, 102: 13200-13205. 10.1073\/pnas.0503133102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"155_CR28","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1158\/0008-5472.CAN-06-0877","volume":"67","author":"Z Chen","year":"2007","unstructured":"Chen Z, Yang J, Wang G, Song B, Li J, Xu Z: Attenuated expression of xeroderma pigmentosum group C is associated with critical events in human bladder cancer carcinogenesis and progression. Cancer Res. 2007, 67: 4578-4585. 10.1158\/0008-5472.CAN-06-0877.","journal-title":"Cancer Res"},{"key":"155_CR29","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1038\/sj.onc.1210284","volume":"26","author":"YH Wu","year":"2007","unstructured":"Wu YH, Tsai Chang JH, Cheng YW, Wu TC, Chen CY, Lee H: Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers. Oncogene. 2007, 26: 4761-4773. 10.1038\/sj.onc.1210284.","journal-title":"Oncogene"},{"key":"155_CR30","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1111\/j.1432-1033.2004.04174.x","volume":"271","author":"G Thiel","year":"2004","unstructured":"Thiel G, Lietz M, Hohl M: How mammalian transcriptional repressors work. Eur J Biochem. 2004, 271: 2855-2862. 10.1111\/j.1432-1033.2004.04174.x.","journal-title":"Eur J Biochem"},{"key":"155_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0065-2660(07)00009-0","volume":"61","author":"E Ballestar","year":"2008","unstructured":"Ballestar E, Esteller M: Epigenetic gene regulation in cancer. Adv Genet. 2008, 61: 247-267.","journal-title":"Adv Genet"},{"key":"155_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mrrev.2008.02.004","volume":"659","author":"T Vaissi\u00e8re","year":"2008","unstructured":"Vaissi\u00e8re T, Sawan Z: Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res. 2008, 659: 40-48. 10.1016\/j.mrrev.2008.02.004.","journal-title":"Mutat Res"},{"key":"155_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00335-009-9206-5","volume":"20","author":"N Valeri","year":"2009","unstructured":"Valeri N, Vannini I, Fanini F, Calore F, Adair B, Fabbri M: Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation. Mamm Genome. 2009, 20: 573-580. 10.1007\/s00335-009-9206-5.","journal-title":"Mamm Genome"},{"key":"155_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4161\/rna.6.3.8329","volume":"6","author":"R Kurokawa","year":"2009","unstructured":"Kurokawa R, Rosenfeld MG, Glass CK: Transcriptional regulation through noncoding RNAs and epigenetic modifications. RNA Biol. 2009, 6: 233-236. 10.4161\/rna.6.3.8329.","journal-title":"RNA Biol"},{"key":"155_CR35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/s-0029-1237423","volume":"27","author":"C Dupont","year":"2009","unstructured":"Dupont C, Armant DR, Brenner CA: Epigenetics: defination, mechanisms and clinical perspective. Semin Reprod Med. 2009, 27: 351-357. 10.1055\/s-0029-1237423.","journal-title":"Semin Reprod Med"},{"key":"155_CR36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1139\/o05-041","volume":"83","author":"L Verdone","year":"2005","unstructured":"Verdone L, Caserta M, Di Maur E: Role of histone acetylation in the control of gene expression. Biochem Cell Biol. 2005, 83: 344-353. 10.1139\/o05-041.","journal-title":"Biochem Cell Biol"},{"key":"155_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12026-007-0085-0","volume":"40","author":"AN Khan","year":"2008","unstructured":"Khan AN, Tomasi TB: Histone deacetylase regulation of immune gene expression in tumor cells. Immunol Res. 2008, 40: 164-178. 10.1007\/s12026-007-0085-0.","journal-title":"Immunol Res"},{"key":"155_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0065-230X(09)02004-1","volume":"102","author":"SC Kampranis","year":"2009","unstructured":"Kampranis SC, Tsichlis PN: Histone demethylases and cancer. Adv Cancer Res. 2009, 102: 103-169.","journal-title":"Adv Cancer Res"},{"key":"155_CR39","doi-asserted-by":"publisher","first-page":"27117","DOI":"10.1074\/jbc.M602826200","volume":"281","author":"SL Colton","year":"2006","unstructured":"Colton SL, Xu XS, Wang AY, Wang G: The involvement of Ataxia-telangiectasia Mutated protein activation in nucleotide excision repair-facilitated cell survival with cisplatin treatment. J Biol Chem. 2006, 281: 27117-27125. 10.1074\/jbc.M602826200.","journal-title":"J Biol Chem"},{"key":"155_CR40","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/dna.2008.0815","volume":"28","author":"SL Lomonaco","year":"2009","unstructured":"Lomonaco SL, Xu XS, Wang G: The role of Bcl-x(L) protein in nucleotide excision repair-facilitated cell protection against cisplatin-induced apoptosis. DNA & Cell Biology. 2009, 28: 285-294. 10.1089\/dna.2008.0815.","journal-title":"DNA & Cell Biology"},{"key":"155_CR41","doi-asserted-by":"publisher","first-page":"38230","DOI":"10.1074\/jbc.M206064200","volume":"277","author":"J Won","year":"2002","unstructured":"Won J, Yim J, Kim TK: Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J Biol Chem. 2002, 277: 38230-38238. 10.1074\/jbc.M206064200.","journal-title":"J Biol Chem"},{"key":"155_CR42","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1073\/pnas.0737363100","volume":"100","author":"H Ryu","year":"2003","unstructured":"Ryu H, Lee J, Olofsson BA, Mwidau A, Dedeoglu A, Escudero M, Flemington E, Azizkhan-Clifford J, Ferrante RJ, Ratan RR: Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci USA. 2003, 100: 4281-4286. 10.1073\/pnas.0737363100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"155_CR43","first-page":"2624","volume":"63","author":"S Zhao","year":"2003","unstructured":"Zhao S, Venkatasubbarao K, Li S, Freeman JW: Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. Cancer Res. 2003, 63: 2624-2630.","journal-title":"Cancer Res"},{"key":"155_CR44","doi-asserted-by":"publisher","first-page":"5340","DOI":"10.1038\/sj.onc.1207689","volume":"23","author":"T Yokota","year":"2004","unstructured":"Yokota T, Matsuzaki Y, Miyazawa K, Zindy F, Roussel MF, Sakai T: Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Oncogene. 2004, 23: 5340-5349. 10.1038\/sj.onc.1207689.","journal-title":"Oncogene"},{"key":"155_CR45","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/j.1471-4159.2009.06385.x","volume":"111","author":"Z Marinova","year":"2009","unstructured":"Marinova Z, Ren M, Wendland JR, Leng Y, Liang MH, Yasuda S, Leeds P, Chuang DM: Valproic acid induces functional heat-shock protein 70 via Class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation. J Neurochem. 2009, 111: 976-987. 10.1111\/j.1471-4159.2009.06385.x.","journal-title":"J Neurochem"},{"key":"155_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/onc.2008.371","volume":"28","author":"D Mottet","year":"2009","unstructured":"Mottet D, Pirotte S, Lamour V, Hagedorn M, Javerzat S, Bikfalvi A, Bellahc\u00e8ne A, Verdin E, Castronovo V: HDAC4 represses p21(WAF1\/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism. Oncogene. 2009, 28: 243-256. 10.1038\/onc.2008.371.","journal-title":"Oncogene"},{"key":"155_CR47","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1600-0463.2005.apm_04.x","volume":"113","author":"J Song","year":"2005","unstructured":"Song J, Noh JH, Lee JH, Eun JW, Ahn YM, Kim SY, Lee SH, Park WS, Yoo NJ, Lee JY, Nam SW: Increased expression of histone deacetylase 2 is found in human gastric cancer. APMIS. 2005, 113: 264-268. 10.1111\/j.1600-0463.2005.apm_04.x.","journal-title":"APMIS"},{"key":"155_CR48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-2164-7-90","volume":"7","author":"H Ozda","year":"2006","unstructured":"Ozda H, Teschendorff AE, Ahmed AA, Hyland SJ, Blenkiron C, Bobrow L, Veerakumarasivam A, Burtt G, Subkhankulova T, Arends MJ, Collins VP, Bowtell D, Kouzarides T, Brenton JD, Caldas C: Differential expression of selected histone modifier genes in human solid cancers. BMC Genomics. 2006, 7: 90-10.1186\/1471-2164-7-90.","journal-title":"BMC Genomics"},{"key":"155_CR49","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.bjc.6604199","volume":"98","author":"W Weichert","year":"2008","unstructured":"Weichert W, R\u00f6ske A, Gekeler V, Beckers T, Stephan C, Jung K, Fritzsche FR, Niesporek S, Denkert C, Dietel M, Kristiansen G: Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. Br J Cancer. 2008, 98: 604-610. 10.1038\/sj.bjc.6604199.","journal-title":"Br J Cancer"},{"key":"155_CR50","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/1471-2407-8-381","volume":"8","author":"FR Fritzsche","year":"2008","unstructured":"Fritzsche FR, Weichert W, R\u00f6ske A, Gekeler V, Beckers T, Stephan C, Jung K, Scholman K, Denkert C, Dietel M, Kristiansen G: Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer. BMC Cancer. 2008, 8: 381-10.1186\/1471-2407-8-381.","journal-title":"BMC Cancer"},{"key":"155_CR51","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3802\/jgo.2008.19.3.185","volume":"19","author":"KL Jin","year":"2008","unstructured":"Jin KL, Pak JH, Park JY, Choi WH, Lee JY, Kim JH, Nam JH: Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissues. J Gynecol Oncol. 2008, 19: 185-190. 10.3802\/jgo.2008.19.3.185.","journal-title":"J Gynecol Oncol"},{"issue":"54","key":"155_CR52","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s10620-008-0601-7","volume":"2","author":"H Ashktorab","year":"2009","unstructured":"Ashktorab H, Belgrave K, Hosseinkhah F, Brim H, Nouraie M, Takkikto M, Hewitt S, Lee EL, Dashwood RH, Smoot D: Global histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma. Dig Dis Sci. 2009, 2 (54): 2109-2117.","journal-title":"Dig Dis Sci"},{"key":"155_CR53","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1365-2559.2009.03290.x","volume":"54","author":"L Marquard","year":"2009","unstructured":"Marquard L, Poulsen CB, Gjerdrum LM, de Nully Brown P, Christensen IJ, Jensen PB, Sehested M, Johansen P, Ralfkiaer E: Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas. Histopathology. 2009, 54: 688-698. 10.1111\/j.1365-2559.2009.03290.x.","journal-title":"Histopathology"},{"key":"155_CR54","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.eururo.2003.10.005","volume":"45","author":"K Halkidou","year":"2004","unstructured":"Halkidou K, Cook S, Leung HY, Neal DE, Robson CN: Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate. Eur Urol. 2004, 45: 382-389. 10.1016\/j.eururo.2003.10.005.","journal-title":"Eur Urol"},{"key":"155_CR55","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1091\/mbc.E08-02-0139","volume":"19","author":"AJ Wilson","year":"2008","unstructured":"Wilson AJ, Byun DS, Nasser S, Murray LB, Ayyanar K, Arango D, Figueroa M, Melnick A, Kao GD, Augenlicht LH, Mariadason JM: HDAC4 promotes growth of colon cancer cells via repression of p21. Mol Biol Cell. 2008, 19: 4062-4075. 10.1091\/mbc.E08-02-0139.","journal-title":"Mol Biol Cell"},{"key":"155_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/187152007779314044","volume":"7","author":"V Cepeda","year":"2007","unstructured":"Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, P\u00e9rez JM: Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem. 2007, 7: 3-28. 10.2174\/187152007779314044.","journal-title":"Anticancer Agents Med Chem"},{"key":"155_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.critrevonc.2007.02.001","volume":"63","author":"DJ Stewart","year":"2007","unstructured":"Stewart DJ: Mechanisms of resistance to cisplatin and carboplatin. Crit Rev Oncol Hematol. 2007, 63: 12-31. 10.1016\/j.critrevonc.2007.02.001.","journal-title":"Crit Rev Oncol Hematol"},{"key":"155_CR58","first-page":"172","volume":"1806","author":"B K\u00f6berle","year":"2010","unstructured":"K\u00f6berle B, Tomicic MT, Usanova S, Kaina B: Cisplatin resistance: preclinical findings and clinical implications. Biochim Biophys Acta. 2010, 1806: 172-182.","journal-title":"Biochim Biophys Acta"},{"key":"155_CR59","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/cncr.22743","volume":"110","author":"YH Wu","year":"2007","unstructured":"Wu YH, Cheng YW, Chang JT, Wu TC, Chen CY, Lee H: Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer. Cancer. 2007, 110: 215-223. 10.1002\/cncr.22743.","journal-title":"Cancer"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-8722-4-17.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:49:07Z","timestamp":1630504147000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/1756-8722-4-17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,20]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["155"],"URL":"https:\/\/doi.org\/10.1186\/1756-8722-4-17","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,20]]},"assertion":[{"value":"9 February 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"17"}}